ACC Schedule 2015: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (23 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
Here is the page we will use to coordinate the TV events at ACC 2015. Open time slots are indicated below in red. | Here is the page we will use to coordinate the TV events at ACC 2015. Open time slots are indicated below in red. | ||
Filming Location: | Filming Location: Manchester Grand Hyatt, 1 Market St, San Diego, CA 92101 | ||
---- | ---- | ||
__NOTOC__ | __NOTOC__ | ||
| Line 56: | Line 57: | ||
===2:00 PM=== | ===2:00 PM=== | ||
*'''Interviewee:''' Dr. Nicolai Tegn | |||
*'''Topic:''' After Eight Study | |||
*'''Embargo Lift:''' Monday March 16, 2015 at 11:45AM | |||
===2:30 PM=== | ===2:30 PM=== | ||
| Line 82: | Line 85: | ||
===9:00 AM=== | ===9:00 AM=== | ||
*'''Interviewee:''' Dr. Philippe Généreux | |||
*'''Topic:''' ACC 2015 Wrap-Up in French | |||
===9:30 AM=== | ===9:30 AM=== | ||
| Line 94: | Line 98: | ||
===11:00 AM=== | ===11:00 AM=== | ||
*'''Interviewee:''' Dr. Luigi Di Biase | |||
*'''Topic:''' Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted device: Results from the AATAC Multicenter Randomized Trial | |||
*'''Embargo Lift:''' Monday March 16, 2015 at 8:00AM | |||
===11:30 AM=== | ===11:30 AM=== | ||
*'''Interviewee:''' Dr. Derek J. Hausenloy | |||
*'''Topic:''' Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Multi-Center Randomized Controlled Clinical Trial | |||
*'''Embargo Lift:''' Monday March 16, 2015 at 9:00AM | |||
===12:00 PM=== | ===12:00 PM=== | ||
| Line 106: | Line 114: | ||
===1:00 PM=== | ===1:00 PM=== | ||
*'''Interviewee:''' Dr. Giora Weisz | |||
*'''Topic:''' ACC 2015 "Impact of the PEGASUS Trial on Clinical Practice" | |||
===1:30 PM=== | ===1:30 PM=== | ||
*'''Interviewee:''' Dr. Michael J. Mack | |||
*'''Topic:''' Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of the PARTNER 1 Trial | |||
*'''Embargo Lift:''' Sunday March 15, 2015 at 10:45AM | |||
===2:00 PM=== | ===2:00 PM=== | ||
| Line 126: | Line 137: | ||
===3:30 PM=== | ===3:30 PM=== | ||
*'''Interviewee:''' Dr. Alexandra J. Lansky | |||
*'''Topic:''' First Report of the DEFLECT III Trial Results: A Prospective Randomized Evaluation of The TriGuardTM HDH Embolic DEFLECTion Device During Transcatheter Aortic Valve Replacement | |||
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:30AM | |||
===4:00 PM=== | ===4:00 PM=== | ||
*'''Interviewee:''' Dr. Basil Lewis | |||
*'''Topic:''' ACC 2015 Wrap-Up in Hebrew | |||
===4:30 PM=== | ===4:30 PM=== | ||
*'''Interviewee:''' Dr. Michael J. Reardon | |||
*'''Topic:''' A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes | |||
*'''Embargo Lift:''' Sunday March 15, 2015 at 11:00AM | |||
===5:00 PM=== | ===5:00 PM=== | ||
| Line 142: | Line 158: | ||
===8:00 AM=== | ===8:00 AM=== | ||
<font color=red>OPEN TIME SLOT</font> | |||
===8:30 AM=== | |||
*'''Interviewee:''' Dr. Renato Lopes | *'''Interviewee:''' Dr. Renato Lopes | ||
*'''Topic:''' ACC 2015 Wrap-Up in Portuguese | *'''Topic:''' ACC 2015 Wrap-Up in Portuguese | ||
===9:00 AM=== | ===9:00 AM=== | ||
| Line 155: | Line 171: | ||
===10:00 AM=== | ===10:00 AM=== | ||
*'''Interviewee:''' Dr. Philip A. Aylward | |||
*'''Topic:''' ACC 2015 Wrap-Up from perspective of the Pacific Rim | |||
===10:30 AM=== | ===10:30 AM=== | ||
*'''Interviewee:''' Dr. | *'''Interviewee:''' Dr. Daniel B. Mark | ||
*'''Topic:''' | *'''Topic:''' Economic Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected CAD: Results from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) Trial | ||
*'''Embargo Lift:''' Sunday March 15, 2015 at | *'''Embargo Lift:''' Sunday March 15, 2015 at 9:00AM | ||
===11:00 AM=== | ===11:00 AM=== | ||
| Line 168: | Line 185: | ||
===11:30 AM=== | ===11:30 AM=== | ||
*'''Interviewee:''' Dr. Rajeev K. Pathak | |||
*'''Topic:''' Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study) | |||
*'''Embargo Lift:''' Monday March 16, 2015 at 8:30AM | |||
===12:00 PM=== | ===12:00 PM=== | ||
| Line 190: | Line 209: | ||
===2:30 PM=== | ===2:30 PM=== | ||
*'''Interviewee:''' Dr. Pamela S. Douglas | |||
*'''Topic:''' A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain) | |||
*'''Embargo Lift:''' Saturday March 14, 2015 at 9:05AM | |||
===3:00 PM=== | ===3:00 PM=== | ||
| Line 198: | Line 219: | ||
===3:30 PM=== | ===3:30 PM=== | ||
*'''Interviewee:''' Dr. Marc Steven Sabatine | |||
*'''Topic:''' Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes | |||
*'''Embargo Lift:''' Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively | |||
===4:00 PM=== | ===4:00 PM=== | ||
*'''Interviewee:''' Dr. Roxana Mehran | |||
*'''Topic:''' A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention | |||
*'''Embargo Lift:''' Sunday March 15, 2015 at 8:30AM | |||
===4:30 PM=== | ===4:30 PM=== | ||
*'''Interviewee:''' Dr. Thomas Engstrøm | |||
*'''Topic:''' The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease | |||
*'''Embargo Lift:''' Monday March 16, 2015 at 11:30AM | |||
===5:00 PM=== | ===5:00 PM=== | ||
Latest revision as of 15:20, 11 March 2015
Here is the page we will use to coordinate the TV events at ACC 2015. Open time slots are indicated below in red.
Filming Location: Manchester Grand Hyatt, 1 Market St, San Diego, CA 92101
Click on Date for Detailed Schedule
Saturday, March 14, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
- Interviewee: Dr. Nicolai Tegn
- Topic: After Eight Study
- Embargo Lift: Monday March 16, 2015 at 11:45AM
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT
Sunday, March 15, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
- Interviewee: Dr. Philippe Généreux
- Topic: ACC 2015 Wrap-Up in French
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
- Interviewee: Dr. Luigi Di Biase
- Topic: Ablation vs. Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted device: Results from the AATAC Multicenter Randomized Trial
- Embargo Lift: Monday March 16, 2015 at 8:00AM
11:30 AM
- Interviewee: Dr. Derek J. Hausenloy
- Topic: Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patients Undergoing Coronary Artery Bypass Graft Surgery: A Multi-Center Randomized Controlled Clinical Trial
- Embargo Lift: Monday March 16, 2015 at 9:00AM
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
- Interviewee: Dr. Giora Weisz
- Topic: ACC 2015 "Impact of the PEGASUS Trial on Clinical Practice"
1:30 PM
- Interviewee: Dr. Michael J. Mack
- Topic: Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of the PARTNER 1 Trial
- Embargo Lift: Sunday March 15, 2015 at 10:45AM
2:00 PM
- Interviewee: Dr. Paul Sorajja
- Topic: Outcomes of the Initial Experience with Commercial Transcatheter Mitral Valve Repair in the United States
- Embargo Lift: Sunday March 15, 2015 at 11:45AM
2:30 PM
- Interviewee: Dr. David E. Newby
- Topic: Computed Tomography Coronary Angiography In Patients With Suspected Angina Due To Coronary Heart Disease
- Embargo Lift: Sunday March 15, 2015 at 8:45AM
3:00 PM
- Interviewee: Dr. Freek W. A. Verheugt
- Topic: ACC 2015 Wrap-Up from perspective of the Netherlands
3:30 PM
- Interviewee: Dr. Alexandra J. Lansky
- Topic: First Report of the DEFLECT III Trial Results: A Prospective Randomized Evaluation of The TriGuardTM HDH Embolic DEFLECTion Device During Transcatheter Aortic Valve Replacement
- Embargo Lift: Sunday March 15, 2015 at 11:30AM
4:00 PM
- Interviewee: Dr. Basil Lewis
- Topic: ACC 2015 Wrap-Up in Hebrew
4:30 PM
- Interviewee: Dr. Michael J. Reardon
- Topic: A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis Deemed at Increased Risk for Surgery 2-Year Outcomes
- Embargo Lift: Sunday March 15, 2015 at 11:00AM
5:00 PM
- Interviewee: Dr. Seung-Jung Park
- Topic: Everolimus-Eluting Stents versus Bypass Surgery for Multivessel Coronary Artery Disease
- Embargo Lift: Monday March 16, 2015 at 8:45AM
Monday, March 16, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
- Interviewee: Dr. Renato Lopes
- Topic: ACC 2015 Wrap-Up in Portuguese
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
- Interviewee: Dr. Philip A. Aylward
- Topic: ACC 2015 Wrap-Up from perspective of the Pacific Rim
10:30 AM
- Interviewee: Dr. Daniel B. Mark
- Topic: Economic Comparison of Anatomic Versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected CAD: Results from the PROspective Multicenter Imaging Study for Evaluation of chest pain (PROMISE) Trial
- Embargo Lift: Sunday March 15, 2015 at 9:00AM
11:00 AM
- Interviewee: Dr. Marc Gillinov
- Topic: Effectiveness of Surgical Ablation of Atrial Fibrillation during Mitral Valve Surgery: A Randomized Clinical Trial from the Cardiothoracic Surgical Trials Network
- Embargo Lift: Monday March 16, 2015 at 8:15AM
11:30 AM
- Interviewee: Dr. Rajeev K. Pathak
- Topic: Long-Term Effect of Goal Directed Weight Management on an Atrial Fibrillation Cohort: A 5-Year Follow-Up Study (LEGACY Study)
- Embargo Lift: Monday March 16, 2015 at 8:30AM
12:00 PM
OPEN TIME SLOT
12:30 PM
- Interviewee: Dr. Rino Sardella
- Topic: ACC 2015 Wrap-Up in Italian
1:00 PM
- Interviewee: Dr. Hisao Ogawa
- Topic: ACC 2015 Wrap-Up in Japanese
1:30 PM
- Interviewee: Dr. Susheel Kodali
- Topic: Early Clinical and Echocardiographic Outcomes with the SAPIEN 3 Transcatheter Aortic Valve Replacement System in Inoperable, High-Risk and Intermediate-Risk Aortic Stenosis Patients
- Embargo Lift: Sunday March 15, 2015 at 11:15AM
2:00 PM
OPEN TIME SLOT
2:30 PM
- Interviewee: Dr. Pamela S. Douglas
- Topic: A Randomized Comparison of Anatomic versus Functional Diagnostic Testing Strategies in Symptomatic Patients with Suspected Coronary Artery Disease: Results from the PROMISE Trial (PROspective Multicenter Imaging Study for Evaluation of chest pain)
- Embargo Lift: Saturday March 14, 2015 at 9:05AM
3:00 PM
- Interviewee: Dr. Marco Valgimigli
- Topic: Transradial Versus Transfemoral Access In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Access Site Program & Bivalirudin Infusion Compared To Unfractionated Heparin In Patients With Acute Coronary Syndromes Undergoing Invasive Management: Results From The Minimizing Adverse Haemorrhagic Events By Transradial Access Site And Systemic Implementation Of Angiox (matrix) Anti-thrombin Program
- Embargo Lift: Monday March 16, 2015 at 11:00AM & Monday March 16, 2015 at 11:15AM, respectively
3:30 PM
- Interviewee: Dr. Marc Steven Sabatine
- Topic: Prevention of Cardiovascular Events in Patients with Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of Aspirin (PEGASUS) - Thrombolysis in Myocardial Infarction (TIMI) 54 & Effect of the PCSK9 Inhibitor Evolocumab on Cardiovascular Outcomes
- Embargo Lift: Saturday March 14, 2015 at 9:30AM & Sunday March 15, 2015 at 8:00AM, respectively
4:00 PM
- Interviewee: Dr. Roxana Mehran
- Topic: A Randomized, Open-Label, Multi-Center, Active-Controlled, Parallel Group Study To Determine the Efficacy and Safety of the REG1 Anticoagulation System Compared to Bivalirudin in Patients Undergoing Percutaneous Coronary Intervention
- Embargo Lift: Sunday March 15, 2015 at 8:30AM
4:30 PM
- Interviewee: Dr. Thomas Engstrøm
- Topic: The Third DANish Study of Optimal Acute Treatment of Patients with ST-segment Elevation Myocardial Infarction: PRImary PCI in MULTIvessel Disease
- Embargo Lift: Monday March 16, 2015 at 11:30AM
5:00 PM
- Interviewee: Prof. Dr. Sigmund Silber
- Topic: ACC 2015 Wrap-Up in German
Tuesday, March 17, 2015
8:00 AM
OPEN TIME SLOT
8:30 AM
OPEN TIME SLOT
9:00 AM
OPEN TIME SLOT
9:30 AM
OPEN TIME SLOT
10:00 AM
OPEN TIME SLOT
10:30 AM
OPEN TIME SLOT
11:00 AM
OPEN TIME SLOT
11:30 AM
OPEN TIME SLOT
12:00 PM
OPEN TIME SLOT
12:30 PM
OPEN TIME SLOT
1:00 PM
OPEN TIME SLOT
1:30 PM
OPEN TIME SLOT
2:00 PM
OPEN TIME SLOT
2:30 PM
OPEN TIME SLOT
3:00 PM
OPEN TIME SLOT
3:30 PM
OPEN TIME SLOT
4:00 PM
OPEN TIME SLOT
4:30 PM
OPEN TIME SLOT